Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma
Titel:
Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma
Auteur:
Dickinson, Michael Briones, Javier Herrera, Alex F. González-Barca, Eva Ghosh, Nilanjan Cordoba, Raul Rutherford, Sarah C. Bournazou, Eirini Labriola-Tompkins, Emily Franjkovic, Izolda Chesne, Evelyne Brouwer-Visser, Jurriaan Lechner, Katharina Brennan, Barbara Nüesch, Eveline DeMario, Mark Rüttinger, Dominik Kornacker, Martin Hutchings, Martin